Hepatitis Vaccine Market 2027 By Indication, Vaccine Type, Distribution Channel | The Insight Partners

Hepatitis Vaccine Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Indication (Hepatitis A, Hepatitis B); Vaccine Type (Recombinant Vaccine, Inactivated Vaccine); Distribution Channel (Hospitals, Retail Pharmacy, Online Pharmacy)

Report Code: TIPRE00007726 | No. of Pages: 151 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Hepatitis is a communicable disease caused due to hepatitis virus types A, B, and C, which leads to associated liver diseases such as Hepatitis A, hepatitis B, hepatitis C, liver cirrhosis, hepatocellular carcinoma, and liver failure. It may lead to the death of the infected person. The infection is spread due to the transmission of hepatitis A, and hepatitis B. Hepatitis vaccine is available for the prevention of both hepatitis A and hepatitis B, that prevents its occurrence by raising the immunity of the person, thereby avoiding complications such as liver failure and cancer.

MARKET DYNAMICS

The hepatitis vaccine market has risen in a number of cases in the hepatitis B virus is anticipated to drive the market growth. However, due to highly expensive medicine, it is restraining the hepatitis vaccine market. Moreover, the rise in the awareness of hepatitis infection prevention among people, coupled with numerous government across the globe rolling out hepatitis immunization schedules, are the factors driving the market growth.

MARKET SCOPE

The "Hepatitis Vaccine Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in hepatitis vaccine market with detailed market segmentation by indication, vaccine type, distribution channel and geography. The hepatitis vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in hepatitis vaccine market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The hepatitis vaccine market is segmented on the basis of indication, vaccine type and distribution channel. Based on indication the market is segmented as hepatitis A and hepatitis B. On the basis of vaccine type the market is categorized as recombinant vaccine and inactivated vaccine. On the basis of distribution channel the market is categorized as hospitals, retail pharmacy and online pharmacy.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in hepatitis vaccine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hepatitis vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting hepatitis vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hepatitis vaccine market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in hepatitis vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in hepatitis vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for in hepatitis vaccine market in the global market. Below mentioned is the list of few companies engaged in the hepatitis vaccine market.

The report also includes the profiles of key in hepatitis vaccine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Astellas Pharma Inc.
  •  Bavarian Nordic
  •  CSL Behring GmbH
  •  GlaxoSmithKline plc.
  •  Johnson & Johnson Services, Inc
  •  Merck & Co., Inc.
  •  Novartis AG
  •  Pfizer Inc.
  •  Sanofi
  •  VBI Vaccines Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hepatitis Vaccine Market - By Indication
1.3.2 Hepatitis Vaccine Market - By Vaccine Type
1.3.3 Hepatitis Vaccine Market - By Distribution Channel
1.3.4 Hepatitis Vaccine Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HEPATITIS VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HEPATITIS VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. HEPATITIS VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. HEPATITIS VACCINE - GLOBAL MARKET OVERVIEW
6.2. HEPATITIS VACCINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. HEPATITIS VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
7.1. OVERVIEW
7.2. INDICATION MARKET FORECASTS AND ANALYSIS
7.3. HEPATITIS A
7.3.1. Overview
7.3.2. Hepatitis A Market Forecast and Analysis
7.4. HEPATITIS B
7.4.1. Overview
7.4.2. Hepatitis B Market Forecast and Analysis
8. HEPATITIS VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - VACCINE TYPE
8.1. OVERVIEW
8.2. VACCINE TYPE MARKET FORECASTS AND ANALYSIS
8.3. RECOMBINANT VACCINE
8.3.1. Overview
8.3.2. Recombinant Vaccine Market Forecast and Analysis
8.4. INACTIVATED VACCINE
8.4.1. Overview
8.4.2. Inactivated Vaccine Market Forecast and Analysis
9. HEPATITIS VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. RETAIL PHARMACY
9.4.1. Overview
9.4.2. Retail Pharmacy Market Forecast and Analysis
9.5. ONLINE PHARMACY
9.5.1. Overview
9.5.2. Online Pharmacy Market Forecast and Analysis
10. HEPATITIS VACCINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hepatitis Vaccine Market Overview
10.1.2 North America Hepatitis Vaccine Market Forecasts and Analysis
10.1.3 North America Hepatitis Vaccine Market Forecasts and Analysis - By Indication
10.1.4 North America Hepatitis Vaccine Market Forecasts and Analysis - By Vaccine Type
10.1.5 North America Hepatitis Vaccine Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Hepatitis Vaccine Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hepatitis Vaccine Market
10.1.6.1.1 United States Hepatitis Vaccine Market by Indication
10.1.6.1.2 United States Hepatitis Vaccine Market by Vaccine Type
10.1.6.1.3 United States Hepatitis Vaccine Market by Distribution Channel
10.1.6.2 Canada Hepatitis Vaccine Market
10.1.6.2.1 Canada Hepatitis Vaccine Market by Indication
10.1.6.2.2 Canada Hepatitis Vaccine Market by Vaccine Type
10.1.6.2.3 Canada Hepatitis Vaccine Market by Distribution Channel
10.1.6.3 Mexico Hepatitis Vaccine Market
10.1.6.3.1 Mexico Hepatitis Vaccine Market by Indication
10.1.6.3.2 Mexico Hepatitis Vaccine Market by Vaccine Type
10.1.6.3.3 Mexico Hepatitis Vaccine Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Hepatitis Vaccine Market Overview
10.2.2 Europe Hepatitis Vaccine Market Forecasts and Analysis
10.2.3 Europe Hepatitis Vaccine Market Forecasts and Analysis - By Indication
10.2.4 Europe Hepatitis Vaccine Market Forecasts and Analysis - By Vaccine Type
10.2.5 Europe Hepatitis Vaccine Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Hepatitis Vaccine Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hepatitis Vaccine Market
10.2.6.1.1 Germany Hepatitis Vaccine Market by Indication
10.2.6.1.2 Germany Hepatitis Vaccine Market by Vaccine Type
10.2.6.1.3 Germany Hepatitis Vaccine Market by Distribution Channel
10.2.6.2 France Hepatitis Vaccine Market
10.2.6.2.1 France Hepatitis Vaccine Market by Indication
10.2.6.2.2 France Hepatitis Vaccine Market by Vaccine Type
10.2.6.2.3 France Hepatitis Vaccine Market by Distribution Channel
10.2.6.3 Italy Hepatitis Vaccine Market
10.2.6.3.1 Italy Hepatitis Vaccine Market by Indication
10.2.6.3.2 Italy Hepatitis Vaccine Market by Vaccine Type
10.2.6.3.3 Italy Hepatitis Vaccine Market by Distribution Channel
10.2.6.4 Spain Hepatitis Vaccine Market
10.2.6.4.1 Spain Hepatitis Vaccine Market by Indication
10.2.6.4.2 Spain Hepatitis Vaccine Market by Vaccine Type
10.2.6.4.3 Spain Hepatitis Vaccine Market by Distribution Channel
10.2.6.5 United Kingdom Hepatitis Vaccine Market
10.2.6.5.1 United Kingdom Hepatitis Vaccine Market by Indication
10.2.6.5.2 United Kingdom Hepatitis Vaccine Market by Vaccine Type
10.2.6.5.3 United Kingdom Hepatitis Vaccine Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hepatitis Vaccine Market Overview
10.3.2 Asia-Pacific Hepatitis Vaccine Market Forecasts and Analysis
10.3.3 Asia-Pacific Hepatitis Vaccine Market Forecasts and Analysis - By Indication
10.3.4 Asia-Pacific Hepatitis Vaccine Market Forecasts and Analysis - By Vaccine Type
10.3.5 Asia-Pacific Hepatitis Vaccine Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Hepatitis Vaccine Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hepatitis Vaccine Market
10.3.6.1.1 Australia Hepatitis Vaccine Market by Indication
10.3.6.1.2 Australia Hepatitis Vaccine Market by Vaccine Type
10.3.6.1.3 Australia Hepatitis Vaccine Market by Distribution Channel
10.3.6.2 China Hepatitis Vaccine Market
10.3.6.2.1 China Hepatitis Vaccine Market by Indication
10.3.6.2.2 China Hepatitis Vaccine Market by Vaccine Type
10.3.6.2.3 China Hepatitis Vaccine Market by Distribution Channel
10.3.6.3 India Hepatitis Vaccine Market
10.3.6.3.1 India Hepatitis Vaccine Market by Indication
10.3.6.3.2 India Hepatitis Vaccine Market by Vaccine Type
10.3.6.3.3 India Hepatitis Vaccine Market by Distribution Channel
10.3.6.4 Japan Hepatitis Vaccine Market
10.3.6.4.1 Japan Hepatitis Vaccine Market by Indication
10.3.6.4.2 Japan Hepatitis Vaccine Market by Vaccine Type
10.3.6.4.3 Japan Hepatitis Vaccine Market by Distribution Channel
10.3.6.5 South Korea Hepatitis Vaccine Market
10.3.6.5.1 South Korea Hepatitis Vaccine Market by Indication
10.3.6.5.2 South Korea Hepatitis Vaccine Market by Vaccine Type
10.3.6.5.3 South Korea Hepatitis Vaccine Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hepatitis Vaccine Market Overview
10.4.2 Middle East and Africa Hepatitis Vaccine Market Forecasts and Analysis
10.4.3 Middle East and Africa Hepatitis Vaccine Market Forecasts and Analysis - By Indication
10.4.4 Middle East and Africa Hepatitis Vaccine Market Forecasts and Analysis - By Vaccine Type
10.4.5 Middle East and Africa Hepatitis Vaccine Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Hepatitis Vaccine Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hepatitis Vaccine Market
10.4.6.1.1 South Africa Hepatitis Vaccine Market by Indication
10.4.6.1.2 South Africa Hepatitis Vaccine Market by Vaccine Type
10.4.6.1.3 South Africa Hepatitis Vaccine Market by Distribution Channel
10.4.6.2 Saudi Arabia Hepatitis Vaccine Market
10.4.6.2.1 Saudi Arabia Hepatitis Vaccine Market by Indication
10.4.6.2.2 Saudi Arabia Hepatitis Vaccine Market by Vaccine Type
10.4.6.2.3 Saudi Arabia Hepatitis Vaccine Market by Distribution Channel
10.4.6.3 U.A.E Hepatitis Vaccine Market
10.4.6.3.1 U.A.E Hepatitis Vaccine Market by Indication
10.4.6.3.2 U.A.E Hepatitis Vaccine Market by Vaccine Type
10.4.6.3.3 U.A.E Hepatitis Vaccine Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hepatitis Vaccine Market Overview
10.5.2 South and Central America Hepatitis Vaccine Market Forecasts and Analysis
10.5.3 South and Central America Hepatitis Vaccine Market Forecasts and Analysis - By Indication
10.5.4 South and Central America Hepatitis Vaccine Market Forecasts and Analysis - By Vaccine Type
10.5.5 South and Central America Hepatitis Vaccine Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Hepatitis Vaccine Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hepatitis Vaccine Market
10.5.6.1.1 Brazil Hepatitis Vaccine Market by Indication
10.5.6.1.2 Brazil Hepatitis Vaccine Market by Vaccine Type
10.5.6.1.3 Brazil Hepatitis Vaccine Market by Distribution Channel
10.5.6.2 Argentina Hepatitis Vaccine Market
10.5.6.2.1 Argentina Hepatitis Vaccine Market by Indication
10.5.6.2.2 Argentina Hepatitis Vaccine Market by Vaccine Type
10.5.6.2.3 Argentina Hepatitis Vaccine Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HEPATITIS VACCINE MARKET, KEY COMPANY PROFILES
12.1. ASTELLAS PHARMA INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BAVARIAN NORDIC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. CSL BEHRING GMBH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GLAXOSMITHKLINE PLC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. JOHNSON AND JOHNSON SERVICES, INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO., INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PFIZER INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SANOFI
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. VBI VACCINES INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Astellas Pharma Inc.
2. Bavarian Nordic
3. CSL Behring GmbH
4. GlaxoSmithKline plc.
5. Johnson & Johnson Services, Inc
6. Merck & Co., Inc.
7. Novartis AG
8. Pfizer Inc.
9. Sanofi
10. VBI Vaccines Inc.
TIPRE00007726
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking